| Oct 23 |
Roche comes out against allowing takeover of drug manufacturer Catalent
|
| Oct 22 |
Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year?
|
| Oct 21 |
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout
|
| Oct 21 |
Catalent’s Maselli to continue as CEO post Novo Holdings deal close
|
| Oct 21 |
Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings
|
| Oct 18 |
European Equities Close Mostly Higher in Friday Trading; Novo Nordisk's Catalent Acquisition Faces Roadblock
|
| Oct 17 |
Consumer, labor groups urge FTC to block Catalent sale to Novo Holdings - report
|
| Oct 17 |
Consumer groups ask FTC to block Novo Holdings-Catalent deal
|
| Oct 16 |
Catalent Stock Flat Following the Sell Agreement With Ardena
|
| Oct 15 |
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
|
